Key result
High-dose simvastatin normalized renal sympathetic nerve activity in rabbits with pacing-induced chronic heart failure.
Why the study?
Does simvastatin improve autonomic neural control in an experimental rabbit model of heart failure?
Does simvastatin improve autonomic neural control in an experimental rabbit model of heart failure?
High-dose simvastatin normalizes sympathetic outflow and reflex regulation in an experimental rabbit model of heart failure, suggesting a non-lipid-lowering mechanism for statin benefits in CHF.
Answers are grounded in this paper and cite their sources.
Does not support statin use for autonomic modulation in heart failure; leaves open pleiotropic mechanisms for clinical investigation.
BACKGROUND: HMG-CoA reductase inhibitors (statins) have been shown to beneficially affect outcomes in chronic heart failure (CHF). We hypothesized that statins exert effects on autonomic function, as assessed by plasma norepinephrine levels, direct recordings of renal sympathetic nerve activity (RSNA), and baroreflex function. METHODS AND RESULTS: Normolipidemic CHF rabbits were treated with simvastatin or vehicle. CHF was induced by continuous ventricular pacing at 320 to 340 bpm for 3 weeks. Two to 3 days after instrumentation of the rabbits with renal nerve electrodes and arterial and venous catheters, blood samples and RSNA recordings were obtained in the conscious state. Baroreflex function was assessed after administration of sodium nitroprusside and phenylephrine. Mean baseline RSNA (+/-SEM) in normal rabbits was 19.3+/-3.8%; in CHF rabbits, 39.4+/-2.9% (P<0.05); in CHF rabbits on low-dose (0.3 mg x kg(-1) x d(-1)) simvastatin, 39.8+/-8.3% (P<0.05); and in CHF rabbits on high-dose simvastatin (3 mg x kg(-1) x d(-1)), 21.1+/-4.5% (P=NS). Similar data were observed for plasma norepinephrine. In CHF rabbits treated with 3 mg x kg(-1) x d(-1) simvastatin, baroreflex regulation of heart rate to transient hypotension with sodium nitroprusside was normalized by 66% compared with CHF controls. CONCLUSIONS: These are the first data showing that non-lipid-lowering statin effects include a normalization of sympathetic outflow and reflex regulation in CHF. The precise neural and cellular pathways involved in these responses need further clarification. This finding may have important implications for the treatment of CHF and progression of the disease process.
No takes yet. Share an insight, caveat, or question.
Pliquett et al. (2003) studied Chronic heart failure (experimental). Simvastatin vs. Vehicle (CHF controls) was evaluated on Mean baseline renal sympathetic nerve activity (RSNA). High-dose simvastatin normalized renal sympathetic nerve activity in rabbits with pacing-induced chronic heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: